Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Valeritas Holdings Inc (VLRX)

Valeritas Holdings Inc (VLRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,335
  • Shares Outstanding, K 5,309
  • Annual Sales, $ 26,400 K
  • Annual Income, $ -45,930 K
  • 60-Month Beta 1.77
  • Price/Sales 0.56
  • Price/Cash Flow N/A
  • Price/Book 9.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -2.90
  • Number of Estimates 1
  • High Estimate -2.90
  • Low Estimate -2.90
  • Prior Year -12.40
  • Growth Rate Est. (year over year) +76.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.50 +6.80%
on 06/25/19
4.28 -37.62%
on 07/10/19
-0.33 (-11.00%)
since 06/19/19
3-Month
2.10 +27.14%
on 05/24/19
7.66 -65.14%
on 05/07/19
-3.37 (-55.79%)
since 04/18/19
52-Week
2.10 +27.14%
on 05/24/19
33.80 -92.10%
on 08/01/18
-28.13 (-91.33%)
since 07/19/18

Most Recent Stories

More News
Thinking about buying stock in Aurora Cannabis, Camber Energy, McDermott International, Vislink Technologies, or Valeritas Holdings?

InvestorsObserver issues critical PriceWatch Alerts for ACB, CEI, MDR, VISL, and VLRX.

ACBFF : 8.6900 (-12.80%)
VLRX : 2.67 (-1.11%)
CEI : 2.12 (-6.19%)
MDR : 10.43 (+2.15%)
Valeritas' V-Go(R) Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, announced today positive data from a retrospective study using the HealthCore...

IREHF : 1.9500 (unch)
VLRX : 2.67 (-1.11%)
Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go(R) Wearable Insulin Delivery Device

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, today announced it has filed a "Special 510(k): Device Modification" submission...

VLRX : 2.67 (-1.11%)
Valeritas Announces Milestone of 20 Million V-Go(R) Insulin Delivery Devices Sold

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, announced today it has surpassed a significant milestone of selling more than...

VLRX : 2.67 (-1.11%)
Valeritas' V-Go(R) Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a Basal Insulin Regimen to Basal-Bolus Delivery

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, today announced additional positive data from the VERDICT study was presented at...

VLRX : 2.67 (-1.11%)
Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, today announced that the Compensation Committee of Valeritas' Board of Directors...

VLRX : 2.67 (-1.11%)
Valeritas to Participate in the American Diabetes Association's 79th Scientific Sessions; Company Reiterates Second Quarter and Full-Year 2019 Revenue Guidance

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, announced today it will participate in this year's American Diabetes Association's...

VLRX : 2.67 (-1.11%)
Valeritas Announces Reverse Stock Split

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes,...

VLRX : 2.67 (-1.11%)
Valeritas Exhibits at Taking Control of Your Diabetes Conferences

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes,...

VLRX : 2.67 (-1.11%)
Valeritas Holdings, Inc. (VLRX) Reports Q1 Loss, Tops Revenue Estimates

Valeritas Holdings, Inc. (VLRX) delivered earnings and revenue surprises of 0.00% and 3.27%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

VLRX : 2.67 (-1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade VLRX with:

Business Summary

Valeritas Holdings Inc. is a commercial-stage medical technology company which focused on developing technologies for Type 2 diabetes. The company's product pipeline consists of V-Go (R) Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for Type 2 diabetes...

See More

Key Turning Points

2nd Resistance Point 2.80
1st Resistance Point 2.73
Last Price 2.67
1st Support Level 2.61
2nd Support Level 2.55

See More

52-Week High 33.80
Fibonacci 61.8% 21.69
Fibonacci 50% 17.95
Fibonacci 38.2% 14.21
Last Price 2.67
52-Week Low 2.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar